|
Dose
|
n
|
Partial response n (%)
|
Full response n (%)
|
Correlation with in vivotest
|
Correlation with t=2 h
|
---|
ACTH1-24
|
10 ng/ml
|
7
|
0
|
6 (86%)
|
−0.39
|
0.20
|
AngII
|
100 nM
|
4
|
0
|
4 (100%)
|
1.00**#
|
n.a.
|
AVP
|
10 nM
|
3
|
0
|
2 (67%)
|
0.50†; n.a.#
|
n.a.
|
AVP
|
100 nM
|
7
|
1 (14%)
|
6 (86%)
|
−0.18†; -0.086#
|
−0.50
|
Desmopressin
|
10 nM
|
5
|
0
|
0
|
−0.67
|
1.00**
|
Metoclopramide
|
1 μM
|
4
|
0
|
2 (50%)
|
0.60
|
1.00**
|
Norepinephrine
|
1 μM
|
4
|
0
|
0
|
−0.50#
|
−0.50#
|
hCG
|
100 IU/ml
|
4
|
0
|
0
|
−0.60
|
−0.50
|
TSH
|
10 nM
|
2
|
0
|
1 (50%)
|
n.a.
|
n.a.
|
Glucagon
|
1 μM
|
4
|
0
|
0
|
−0.20
|
n.a.
|
GIP
|
100 nM
|
2
|
0
|
0
|
−1.00¶
|
n.a.
|
- **p<0.01, ¶ standard mixed meal, # upright posture test, † AVP im, n.a. not applicable.